https://www.selleckchem.com/pr....oducts/gsk2334470.ht
Altogether the reports were of variable bias and quality due to high variability of examined IFN-I biomarkers and inconsistent results for different outcome measures. No studies investigating the cardiovascular risk of circulating IFN-I in CLE, nor FGF-23 in SLE or CLE were found. Clinical studies measuring the association between IFN-I and direct / intermediate measures of CVD are rare and ambiguous in SLE and nonexistent in CLE, hampering a definite conclusion. Clinical studies measuring the association between IFN-I and direct / i
Мне нравится
Комментарий
Перепост
